UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$1.37B |
| 2 |
Apple
AAPL
|
+$1.22B |
| 3 |
Microsoft
MSFT
|
+$1.11B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$885M |
| 5 |
Nike
NKE
|
+$833M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$398M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
+$385M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$351M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$239M |
Sector Composition
| 1 | Technology | 22.16% |
| 2 | Financials | 10.23% |
| 3 | Healthcare | 7.95% |
| 4 | Consumer Discretionary | 7.27% |
| 5 | Communication Services | 6.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Crinetics Pharmaceuticals
CRNX
$3.2B
| $8.19M | ﹤0.01% |
182,942
-64,861
| -26% | -$2.91M |
|
1752
Nuveen Floating Rate Income Fund
JFR
$1.12B
| $8.18M | ﹤0.01% |
945,601
+32,938
| +4% | +$285K |
|
1753
ProShares Investment Grade-Interest Rate Hedged
IGHG
$264M
| $8.18M | ﹤0.01% |
107,184
+21,462
| +25% | +$1.64M |
|
1754
Pinnacle Financial Partners
PNFP
$7.55B
| $8.17M | ﹤0.01% |
102,075
+18,330
| +22% | +$1.47M |
|
1755
Axalta
AXTA
$6.75B
| $8.14M | ﹤0.01% |
238,212
+8,756
| +4% | +$299K |
|
1756
EPR Properties
EPR
$4.45B
| $8.13M | ﹤0.01% |
193,553
-5,160
| -3% | -$217K |
|
1757
Patterson-UTI
PTEN
$2.13B
| $8.09M | ﹤0.01% |
781,346
+292,801
| +60% | +$3.03M |
|
1758
iShares iBonds Dec 2028 Term Treasury ETF
IBTI
$1.1B
| $8.08M | ﹤0.01% |
370,342
+44,464
| +14% | +$971K |
|
1759
Qiagen
QGEN
$9.82B
| $8.07M | ﹤0.01% |
190,941
+44,015
| +30% | +$1.86M |
|
1760
TPG
TPG
$9.05B
| $8.07M | ﹤0.01% |
194,673
-35,286
| -15% | -$1.46M |
|
|
TPC
1761
Tutor Perini Corporation
TPC
$3.37B
| $8.06M | ﹤0.01% |
369,852
+94,626
| +34% | +$2.06M |
|
1762
Ultragenyx Pharmaceutical
RARE
$2.92B
| $8.05M | ﹤0.01% |
195,891
+26,728
| +16% | +$1.1M |
|
1763
IDEAYA Biosciences
IDYA
$2.16B
| $8.03M | ﹤0.01% |
228,805
-14,244
| -6% | -$500K |
|
1764
Element Solutions
ESI
$6.36B
| $8M | ﹤0.01% |
294,919
+14,668
| +5% | +$398K |
|
1765
RLI Corp
RLI
$6.14B
| $7.99M | ﹤0.01% |
113,618
+24,772
| +28% | +$1.74M |
|
1766
Prestige Consumer Healthcare
PBH
$3.11B
| $7.99M | ﹤0.01% |
116,002
-18,341
| -14% | -$1.26M |
|
1767
STAG Industrial
STAG
$6.77B
| $7.98M | ﹤0.01% |
221,251
-52,317
| -19% | -$1.89M |
|
1768
PagerDuty
PD
$1.53B
| $7.96M | ﹤0.01% |
347,095
-61,136
| -15% | -$1.4M |
|
1769
WisdomTree US High Dividend Fund
DHS
$1.3B
| $7.95M | ﹤0.01% |
93,938
-2,782
| -3% | -$235K |
|
1770
Invesco BulletShares 2032 Corporate Bond ETF
BSCW
$1.03B
| $7.95M | ﹤0.01% |
396,854
-111,485
| -22% | -$2.23M |
|
1771
Marcus Corp
MCS
$504M
| $7.94M | ﹤0.01% |
698,169
-582,268
| -45% | -$6.62M |
|
1772
Invesco High Yield Equity Dividend Achievers ETF
PEY
$1.12B
| $7.91M | ﹤0.01% |
402,965
-21,906
| -5% | -$430K |
|
1773
Hyatt Hotels
H
$13.7B
| $7.91M | ﹤0.01% |
52,042
+26,809
| +106% | +$4.07M |
|
1774
Wayfair
W
$11.4B
| $7.88M | ﹤0.01% |
149,532
+25,033
| +20% | +$1.32M |
|
1775
Invesco CEF Income Composite ETF
PCEF
$849M
| $7.88M | ﹤0.01% |
418,822
-172,642
| -29% | -$3.25M |
|